First — Materials and chemistry
Novelty claims for predicted or synthesized compounds depend on exclusion checks against structured databases, so records link to Materials Project, OPTIMADE, and ICSD identifiers, not only to papers.
The first corpus will be assembled with a national-laboratory partner from existing failed and inconclusive autonomous-synthesis and high-throughput computation attempts.
Next — Biology and biomedical evidence synthesis
The biology profile requires control outcomes and a stated detection limit or power analysis, so a negative is recorded as informative only when the assay could have found the effect.
An evidence path is already a methodological requirement here, and redundancy is measured: 31 to 68 percent of systematic reviews overlap an existing review, with failure to find prior reviews as the leading cause.[6][7]
PubMed indexed 43,639 systematic reviews in 2025,[8] and a review takes a mean of 67 weeks.[9]
Prior art — Mathematics
Several 2025 announcements of AI-solved open problems turned out to be results already in the literature.
A record of what was searched, the nearest prior result, and why a claim is new, attached to a machine-checked proof, is the artifact that episode called for.